Beyhan Budak

Beyhan Budak

Auto-generated profile, based on publicly available information

Beyhan Budak

Department of Infectious Diseases and Clinical Microbiology, Cerrahpasa Medical Faculty Istanbul University‐Cerrahpasa Istanbul Turkey

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2022 in Irish Journal of Medical Science (1971 -)
Verified
Journal Article
Closed access
PDF file
IBİlKer İnAnc Balkan
İlKer İnAnc Balkan
HDHarika Öykü Dinç
Harika Öykü Dinç
GCGünay Can
Günay Can
RKRıdvan Karaali
Rıdvan Karaali
DÖDoğukan Özbey
Doğukan Özbey
NSNese Saltoglu
Nese Saltoglu

15 November 2023 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Open access
HCHazal Cansu Culpan
Hazal Cansu Culpan
SASümeyye Nur Aydın
Sümeyye Nur Aydın
AUAbdulkerim Uygur
Abdulkerim Uygur
USUgurcan Sayili
Ugurcan Sayili
EŞErkam Şeker
Erkam Şeker
GCGünay Can
Günay Can
The evidence on the waning protection of COVID-19 vaccines has been reviewed by the World Health Organization and has led to consideration of the need for booster doses. This study aimed to evaluate vaccine effectiveness against COVID-19, and the COVID-19 infections among healthcare workers who received various types (inactive or m-RNA) and doses (2 to 4 doses) of the COVID-19 vaccine. The study was conducted with a total of 3,009 healthcare workers between August 1 and November 30, 2021 at a university hospital. Six different vaccination statuses were evaluated in the study. The effectiveness for COVID-19 infection, after adjusting for age, sex, and position, was highest in those who received two doses of CoronaVac and two doses of BNT162b2 (89.3%, 95% CI 72.2-95.9%) and was lowest in those who received two doses of CoronaVac (29%, 95% CI - 8-53%). The adjusted effectiveness of two doses of CoronaVac for COVID-19 infection was not significant (21.0%, 95% CI - 20.7-48.3%) but increased significantly with a booster dose of CoronaVac or BNT162b2. One or two doses of the BNT162b2 booster demonstrated higher effectiveness in comparison to a single dose of the CoronaVac booster. These results indicate the need for a booster dose, and heterologous boosting with BNT162b2 may be a better option for higher effectiveness for those who received two doses of CoronaVac. Future studies should evaluate the need for further booster doses and their long-term effects.

13 June 2022 in Infectious Diseases and Clinical Microbiology
Verified
Journal Article
Open access
HDHarika Öykü Dinç
Harika Öykü Dinç
IBIlker Inanc Balkan
Ilker Inanc Balkan
BBBeyhan Budak
Beyhan Budak
Mehmet DemirciMehmet Demirci
Mehmet Demirci
DÖDoğukan Özbey
Doğukan Özbey
NSNese Saltoglu
Nese Saltoglu
Despite the decrease in incidence after having widespread vaccination programs, the COVID-19 pandemic continues to cause high morbidity and mortality in the world in its second year. Especially elderly people (over 65 years old), people with underlying health conditions, and healthcare workers (HCWs) are still at high risk for COVID-19 disease. Since […]

18 June 2026 in Journal of Medical Virology
Verified
Journal Article
Open access
HDHarika Öykü Dinç
Harika Öykü Dinç
Hayriye Kırkoyun UysalHayriye Kırkoyun Uysal
Hayriye Kırkoyun Uysal
GCGünay Can
Günay Can
BBBeyhan Budak
Beyhan Budak
Ferhat Osman DaşdemirFerhat Osman Daşdemir
Ferhat Osman Daşdemir
BKBekir Kocazeybek
Bekir Kocazeybek
This study aimed to assess the humoral immune response following administration of a BNT162b2 mRNA COVID‐19 booster dose and to evaluate its association with the development of SARS‐CoV‐2 infection after vaccination. Between July 2021 and February 2022, serum samples were collected from 313 individuals 28 days after receiving a COVID‐19 booster dose. Quantitative SARS‐CoV‐2 IgG antibodies directed against the receptor‐binding domain (RBD) of the spike protein were measured using a chemiluminescent microparticle immunoassay. Neutralizing antibody activity, defined as inhibition of the RBD–ACE2 interaction, was evaluated semi‐quantitatively by a competitive ELISA. Participants were followed for 6 months after the final dose to identify confirmed SARS‐CoV‐2 infections. The cohort included 97 males (31%) and 216 females (69%), with a mean age of 39.43 years. The median SARS‐CoV‐2 IgG antibody level at day 28 was 7713.3 AU/mL, and the median neutralizing antibody inhibition rate was 99.2%. Antibody levels were not significantly associated with age or comorbidities. Booster vaccination induced a strong humoral immune response in all participants. However, the occurrence of post‐vaccination infections despite high antibody levels suggests immune escape by emerging variants. While vaccines may not fully prevent infection, they provide substantial protection against severe disease and mortality.

26 February 2026 in Florence Nightingale Journal of Nursing
Verified
Journal Article
Open access
PDF file
NBNaile Boduç
Naile Boduç
ÖKÖzkan Karadede
Özkan Karadede
BBBeyhan Budak
Beyhan Budak
AIM: The research was conducted to determine nurses’ attitudes toward evidence-based practices and the affecting factors. METHODS: This research was planned as descriptive and cross-sectional. The sample of the research consisted of 275 nurses actively working in a university hospital. A “Personal Information Form” and “Attitude Toward Evidence-Based Nursing Questionnaire” were used to collect the data. Frequency, percentage, kurtosis, skewness, t-test, ANOVA, Tukey, LSD tests, (The Least Significant Difference) and multiple regression analysis were used to evaluate the data. RESULTS: It was found that mean scores of the nurses were 67.856 Å} 7.754 for “total attitude toward evidence-based nursing,” 32.530 Å} 3.617 for “beliefs and expectations toward evidence-based nursing,”17.383 Å} 2.711 for “evidence-based practice intention,” and 17.944 Å} 3.039 for “feelings about evidencebased nursing.” The total score of those who worked on shifts was 66.159 Å} 8.003. The total score of those who followed professional publications on the attitude toward evidence-based nursing questionnaire was 69.141 Å} 7.489. CONCLUSION: It was determined that nurses’ attitudes toward evidence-based practices were positive, shift work reduced the attitude level, and following professional publications increased the attitude level. Cite this article as: Bodu., N., Karadede, .., & Budak, B. (2026). Determination of nurses’ attitudes towards evidence-based practice and affecting factors. Florence Nightingale Journal of Nursing. 34, 0250, doi:10.5152/FNJN.2026.24250.

23 March 2023 in Cerrahpasa Medical Journal
Verified
Journal Article
Closed access
NBNaile Boduç
Naile Boduç
ÖKÖzkan Karadede
Özkan Karadede
AŞAhmet Şen
Ahmet Şen
BBBeyhan Budak
Beyhan Budak
In recent years, the incidence of disasters has increased worldwide due to various reasons, particularly climate change, resulting in death, injury, economic loss, and environmental damage. Recent large-scale earthquakes have reaffirmed that Turkey is a country with high disaster risk. It is possible to prevent or reduce deaths, injuries, and epidemics after disasters by planning before, during, and after disasters. For the sustainability of nursing services in disasters, executive nurses should effectively perform management functions related to planning, organizing, directing, coordinating, and controlling. This study examines the nursing services provided at a university hospital where earthquake victims were transferred following the Kahramanmaraş earthquake that impacted 11 provinces on February 6, 2023. The study uses the Plan, Do, Check, and Act cycle to present the nursing activities, aiming to contribute to disaster nursing literature and guide executive nurses. Cite this article as: Boduç N, Karadede Ö, Şen A, Budak B. Application of the PDCA cycle in the management of nursing services in disasters: The case of a university hospital. Cerrahpaşa Med J 2023;47(S1):78-82.